What did @juliestollkelly actually say?
She said she woke up early specifically to take her missed dose of NAD, BPC-157, and TB-500 because "they've literally changed my life." That's it. No specific health claims, no dosing details, just a strong personal endorsement and a routine injection before crawling back to bed.
To be fair, this is a lifestyle post, not a medical lecture. She's not claiming these peptides treat a disease or prescribing anything to her audience. But 14,000 viewers watching someone describe an urgent early-morning injection routine for compounds most of them have never heard of is not a neutral act. The implicit message is: these are worth your time, your money, and a needle.
Does the science back this up?
Partially, and with serious caveats. BPC-157 and TB-500 have real preclinical data behind them, but almost none of it comes from human trials. That gap matters more than most peptide enthusiasts admit.
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. Animal studies, including work by Sikiric et al. published repeatedly in Current Pharmaceutical Design, show accelerated tendon, muscle, and gut healing in rodents. TB-500 is a synthetic fragment of Thymosin Beta-4, which has shown pro-angiogenic and anti-inflammatory properties in animal and some cardiac surgery contexts (Goldstein et al., 2012, Annals of the New York Academy of Sciences). NAD precursors like NMN and NR have more human data, with Yoshino et al. (2021, Science) showing metabolic improvements in postmenopausal women, though injectable NAD specifically has a thinner evidence base.
The honest summary: promising animal data, weak human data, no FDA approval for any of these as therapeutics.
What did they get wrong (or right)?
She didn't technically get anything wrong because she didn't make a specific medical claim. What she got right, inadvertently, is that these compounds are being used widely in biohacking and recovery communities, and patient-reported outcomes are often positive. That's real, even if anecdote isn't evidence.
What she glossed over is significant. BPC-157 and TB-500 are not FDA-approved. They exist in a regulatory gray zone, available through compounding pharmacies under certain conditions or, less legitimately, through research chemical suppliers. The injection she's describing carries real risks: infection at the injection site, unknown long-term effects, batch-to-batch inconsistency in compounded products, and no standardized dosing established in humans.
Her framing, "that's how much I love these peptides," positions urgency around a missed dose of unapproved compounds. For a general audience, that framing can normalize something that warrants a lot more context than a TikTok allows.
What should you actually know?
If you're curious about peptide therapy, the conversation starts with a licensed provider, not a TikTok comment section. BPC-157 and TB-500 are being used clinically in some telehealth and sports medicine contexts, but the protocols vary widely because the human evidence base is thin enough that no consensus guidelines exist.
The regulatory picture is also shifting. The FDA has moved to restrict certain peptides from compounding, and what's available legally depends on your jurisdiction and how your provider sources the compounds. Compounded peptides are not the same as any brand-name approved drug, and quality control is a legitimate concern.
NAD has a longer human research trail than the two peptides here, with studies exploring its role in cellular energy metabolism and aging. But injectable NAD is not the same as oral NMN or NR, and the bioavailability comparisons are not settled science. Anyone stacking all three of these should be doing so under medical supervision with regular labs, not because someone on TikTok woke up early for their shot.